Gabriel Budi Sutrisno · · 1 min readIndonesia’s Asa Rén raises $8m to grow D2C genetic testing
Asa Rén provides a direct-to-consumer DNA test that can generate more than 360 reports on predisposed health risks and other ancestry genetic analysis for children and adults.
The startup aims to enable innovation in Indonesia’s healthcare industry through the use of data for drug discovery and personalized treatments.
Funding details
- Funding amount: US$8,150,000
- Lead investors: Top Harvest Capital, Kejora Capital, Marcy Venture Partners (MVP)
- Other investors: Northstar Ventures, PT Diagnos Laboratorium Utama Tbk (Diagnos Laboratories)
- Stage: Early Stage
- Source
More details
Asa Rén→
|
||
| Stage | Amount (US$) | Investors |
| Early Stage | 8.2 million | Northstar Ventures, PT Diagnos Laboratorium Utama Tbk (Diagnos Laboratories), Kejora Capital, Marcy Venture Partners (MVP), Top Harvest Capital |
| Total | 8.2 million | |
See also: Indonesian startup that turns mushrooms into leather nabs 6-figure funding
Editing by Thu Huong Le and Dhania Putri Sarahtika
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.
